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Summary.-(AxT6)Fl hybrid mice received s.c. transplants from (AxT6)Fl
mammary carcinomas. At 1, 2 or 4 weeks after tumour transplantation, the mice
were bled to obtain plasma and then challenged with 25 ,tg E. coli lipopolysaccharide
(LPS) endotoxin i.v. The mice were killed 24 h later, further plasma was obtained and
their liver ratios and spleen ratios were determined. A similar procedure was
carried out on non-tumour-bearing mice. Progressive tumour growth was asso-
ciated with an increase in the liver ratio. In parallel, mice with 4-week tumour
transplants showed increased uptake of colloidal carbon particles and 51Cr-labelled
sheep red blood cells in the liver. The plasma amino aspartate transaminase (AST)
and the ornithine carbamoyl transferase (OCT) showed a constant rise in all groups
of mice after LPS injection. However, at 24 h after LPS injection, the AST level
showed the greatest rise in mice with 4-week tumour transplants. By contrast, OCT,
which is liberated only from hepatocytes, showed the greatest rise in non-tumour-
bearing mice.
PHAGOCYTOSIS BY MACROPHAGES can
lead to increased synthesis and release of
various enzymes and cytotoxic factors
from these cells, with consequent damage
to the surrounding tissues, normal and
malignant (Sethi & Brandis, 1975; Currie
& Basham, 1975). In the liver, hepato-
cellular damage can occur during local
macrophage hyperphagocytosis and it has
been proposed that this is due to phago-
cytosis-induced release ofcytotoxic factors
from the hepatic macrophages (Bradfield
& Wells, 1978). When C. parumn is
used to activate these macrophages, with
recruitment of new cells and granuloma
formation, clearance ofinjected endotoxin
from the bloodstream into the liver causes
massive hepatocellular necrosis (Ferluga
& Allison, 1978). A number of other
agents have similarly been used to recruit
and activate hepatic macrophages in
mnice, including mouse hepatitis virus
(Gledhill, 1958) inoculation with BCG
(Satio & Suter 1965; Shands & Senterfitt
1972) and induction of a graft-vs-host
reaction (Howard, 1969). This paper is
concerned with the proposition that the
growth of tumours can lead to the activa-
tion of hepatic macrophages, thus making
the liver susceptible to damage during
clearance of endotoxin from the circula-
tion. Activation of hepatic macrophages
during tumour growth in mice, as shown
by increased colloidal carbon clearance
(Old et al., 1960) suggests that these
macrophages participate in the hosts'
immune response to the tumour.
It was therefore decided to investigate
whether (AxT6)Fl mice bearing early
transplants of (AxT6)Fl mammary car-
cinomas showed any evidence ofactivation
of hepatic macrophages, and whether this
was associated with increased sensitivity
to liver damage by injected lipopoly-
saccharide (LPS).
In general, such a sequence of events
might explain some of the morbidity
associated with neoplasia.LIPOPOLYSACCHARIDE EFFECT ON TUMOUR-BEARING MICE
MATERIALS AND METHODS
Animals and tumours.-Nine-month-old
(A female x CBA(T6) male) F1 hybrid mice
bred inthe Department ofSurgery by crossing
highly inbred A/Mi and CBA-HT6 mice, also
maintained in the Department, were used
throughout the study.
Two mammary carcinomas (referred to as
Tumour 1 and Tumour 2) both arose spon-
taneously in (A x CBA(T6)F1 mice and were
maintained by serial passage in isogenic hosts
at intervals of 3-4 weeks.
Tumour-bearing mice received 106 viable
tumour cells s.c. from one of these tumours.
Tumour-cell suspensions were prepared by
the method of Milas et al. (1974). In brief the
tumour was chopped into small fragments
with scissors. The fragments were disaggre-
gated by stirring at room temperature for
30 min in a balanced salt solution containing
trypsin and DNAase.
Lipopolysaccharide.-LPS endotoxin (Dif-
co) was obtained from E. coli strain 0111 B4 1.
It was kept lypophilised until use. Prior to
injection the powder was dissolved in Medium
199 (Wellcome). 25 jug ofLPS in 0-25 ml were
injected i.v. into each appropriate mouse.
Bleeding of mice.-Mice were bled under
ether anaesthesia either by retro-orbital
venous puncture by one of us (MOS) or
following transection ofthe axillary vessels.
Observation on animals.-Mice were bled
from the eye (pooling the blood from groups
of5) immediately before injection ofLPS. The
mice were also individually bled from the
axillary vessels, 24 h after LPS injection. The
mice were weighed (to the nearest 0-1 g) and
the tumour, liver and spleen were removed
and weighed to the nearest 0-1 mg. The true
bodyweight ofthe mouse (totalbodyweight -
wt of tumour) was determined and used to
calculate the spleen ratio (wt of spleen (mg)/g
body wt) and the liver ratio (wt of liver (g)/
10 g body wt).
Estimation of mouse plasma enzymes.-
The levels of plasma amino aspartate trans-
aminase (AST) were measured by the method
of Wilkinson et al. (1972). Oxaloacetate pro-
duced by the transaminase from 2-oxo-
glutarate serves as a substrate for malate
dehydrogenase, by which it is reduced to
malate in the presence of dehydronicotina-
mide adenine dinucleotide (NADH). NADH
is simultaneously oxidized. NADH has an
absorbance peak at 340 nm. which is not
shown by the oxidized form, and the decrease
in the absorbance at this wavelength provides
a measure ofthe AST activity.
The levels of ornithine carbamoyl trans-
ferase (OCT) were measured by the method of
Vassef (1978). OCT, an enzyme confined
almost exclusively to the liver mitochondria,
catalyses the reaction: Carbamoyl phosphate
+L-ornithine=L-citrulline+phosphate. To
measure OCT levels in serum, 20 pl aliquots of
ornithine, serum and carbamoyl phosphate
were mixed and incubated in a water bath
at 37°C for 60 min. After addition of a colour
reagent mixture (antipyrine+2,3-butane-
dione monoxime) the reactants were placed in
a boiling water bath for 45 min before deter-
mination of the citrulline concentration in
terms ofthe mixture's absorbance at 464 nm.
Studies on the distribution of mouse hepatic
macrophages.-Two groups ofmice, aged 9-12
months, one bearing transplants of tumour 1
(5th passage) for 1 month and the other non-
tumour bearing, each received an i.v. injection
of 8 mg/100 g body wt colloidal carbon C 11/
1431a (Pelican, Gunther Wagner). The mice
were killed 15 min later. The livers were
removed and fixed in formol saline. Sections
were stained with haematoxylin and eosin,
prior to examination for the distribution of
carbon-laden hepatic phagocytic cells.
Studies on increased activity ofmouse hepatic
macrophages.-The increased phagocytic acti-
vitybythehepaticmacrophages wasmeasured
in terms of an increase in the liver uptake of
i.v. injected 51Cr-labelled sheep red blood
cells (SRBC). The SRBC were incubated with
51Cr as sodium chromate, 20 iCi/ml at 37°C
for 45 min, and washed as previously des-
cribed by Souhami (1972). Each mouse
received 5 x 108 i.v. 51Cr labelled SRBC. Half
the mice had received Tumour 2 (8th passage)
one month previously. The remainder of the
mice were non-tumour-bearing. The mice were
killed 4 h later and the y counts oftheir liver
and spleen determined. The counts oftumour-
bearing and normal mice were then com-
pared.
As a further control, non-tumour-bearing
mice, in which phagocytosis was blocked by
prior i.v. administration of 900,000-mol.-wt
dextran sulphate (Pharmacia, Uppsala,
Sweden), 500 ,ug/mouse, 3 h before injection
of SRBC, were included (Bradfield et al.,
1974).
Statistics.-Fordata with a normal distribu-
tion (spleen and liver ratios) significance was
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calculated, following an analysis of variance
on the total data, by using a common variance
based on the residual sum of squares to
calculate Student's t.
The values for AST and OCT did not show,
a normal distribution, so the significance of
differences between the several groups of
mice were calculated using the Wilcoxon
two-sample. rank-sum test.
RESULTS
Alterations in the hepatic macrophages
Three groups of 10 F1 hybrid mice
(5 male, 5 female) each received 106
cells s.c. from Tumour 1, second passage.
In a second experiment similar groups of
mice received cells from Tumour 2, second
passage. These mice were killed at 1, 2 or 4
weeks after tumour transplantation. A
further matched group of 18 non-tumour-
bearing mice (10 male, 8 female) were
used for comparison.
Increase in the numbers and phagocytic
function ofhepatic macrophageswasshown
in 2 ways. First, the liver and spleen ratios
of the above mice are shown in Table I.
There was a significant rise in liver ratio
in animals bearing Tumour 1 for 4 weeks
and in animals with Tumour 2 for 1, 2 or
4 weeks. Thus, the livers in the tumour-
bearing mice were heavier than those in
control animals.
Secondly, the uptake of 5lCr-labelled
SRBC was compared between the livers
and spleens of mice bearing Tumour 2
(passage 8) for 1 month and non-tumour-
bearing mice. As a further control, non-
tumour-bearing mice in which phago-
cytosis was blocked by prior i.v. adminis-
tration of dextran sulphate (500 ,ug/
mouse) were included (Bradfield et al.,
1974). The tumour-bearing mice showed a
significant rise in the liver uptake of
SRBC (at the expense of splenic uptake)
and the mice receiving dextran sulphate a
significant fall (Fig. 1). This increased
uptake of SRBC is more than can be
explained merely by the increase in weight
of the livers in the tumour-bearing mice.
In mice bearing the 5th transplant genera-
tion of Tumour 1 for one month, the dis-
tribution of hepatic phagocytes was dif-
TABLE I. The liver and spleen ratios of(AxT6)Fl mice bearing 2nd generation transplants
of (A x T6)F1 m.ammary Tumours 1 or 2
1Periodl of P (from non-tumour-
groxNtlh Aleani bearing animals)
(,A ks)
(3-5 mice Spleen Liver Spleen Liver
pergroup) Sex ratio* ratiot r'atio ratio
3 21
2-99
5.39
4 50
3 87
7 19
3-24
4443
3 29
3.37
3.33
473
411
4-24
3 24
4.43
0 49 N-S
048 NS
0.64 NS
0 53 NS
0.55 NS
0(60 <001
0-47 (10 mice)
0-53 (8 mice)
0-54 NS
0-52 NS
0 57 NS
(.55 NS
057 NS
0.59 NS
0 47 (10 mice)
0 53 (8 mice)
NS
NS
< 0-0005
NS
NS
< 0-0025
< 0 005
< 0 0025
< 0 0005
NS
< 0 025
< 0-0005
* Spleen xN t (mg)/mouse wvt (g).
t Liver w%t (g)/mouse NNt (10 g).
Tumouir 1
I
4
4
No tutmnour
Tumouir 2
1
4
4
No tuLmnour
M
F
F
F
~AI
F
'
M F
F
F
F
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FiG. 1.-Uptake of 51Cr-SRBC by liver andI
spleen. Hepatic phagocytosis is increased in
tumour-hearing mice and decreased in mice
previously treated with dextran sulphate.
Organ uptake is expressed as total radio-
activity in the organ compared withi the
injected (lose.
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ferent from that in control mice. In the
former, carbon-laden macrophages were
seen throughout the hepatic lobules, as
illustrated by the photomicrograph (Fig.
2) whereas in non-tumour-bearing mice
carbon-containing phagocytic cells were
confined to the periphery of the lobules
(Fig. 3). In the livers of 4-week tumour-
bearing mice, but not in controls, there
were numerous large cells with hyper-
chromatic nuclei both in clumps and singly
within sinusoids. It was not clear whether
these were tumour cells or enlarged
macrophages.
Hepatic damage during clearance of blood
borne endotoxin by activated hepatic
macrophages in mice bearing the second
passage ofTumour I or 2
To obtain values for the plasma AST
and OCT before injection of LPS, mice
were bled from the eye in groups of 5,
with pooling of plasma from the mice in a
given group, prior to determination of
enzyme levels. It was found that the
enzyme concentrations were unaffected
by the presence of a tumour. Therefore, in
Tables II and III the pre-LPS values for
AST and OCT refer to 11 and 14 groups
respectively, each of 5 mice, expressed
without classification according to whether
the mice in a particular group were tumour
bearers. The values for plasma AST and
OCT 24 h after injection of LPS were
obtained from individual mice in particu-
lar groups.
The levels of plasma AST are shown in
Table II. Injection of LPS into non-
tumour-bearing mice produced a signi-
ficant rise in AST level over the levels in
tumour-bearing and non-tumour-bearing
animals which had not received LPS. Mice
TABLE II. The pla.sma amino aspartate transamina8e (AST) level.s in iu/l of (A xT6)Fl
mice. The valuesfor mice before injection of LPS werefor plasma pooledfrom groups of
5 mice. The valuesfor mice bled 24 h after i.v. injection of 25 9g LPS werefor individual
animals
Group
Pre-LPS
No tumour Post-LPS
Tumour I Post-LPS
1 wk growth
2 wk growth
4 wk growth
Tumour 2 Post-LPS
I wk growtlh
2 wk growth
4 wk growth
Amino aspartate transamina
r-
Range
11-2- 54-3
20-5-162-1
n
11
19
35 4- 93-3 8
22-7-122-5 9
35-1-135-1 6
28-4-191-8 10
29-7- 52-7 9
27-7-138-4 8
Mlediai
26-9
43-0
45-8
45-4
62-7
38-4
41-1
50-7
lse From
From post-LPS,
n pre-LPS no tumour
< 0-025
< 0-025
< 0-025 NS
< 0-025 NS
<0-001 =0 05
<0-01 NS
= 0 005 NS
<0-01 <0-05
* Wilcoxon two-sample rank-sum test.
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bearing second-passage transplants of
either Tumour 1 or Tumour 2 for 1 or 2
weeks, showed a similar increase in AST
levels. In contrast, injection of LPS into
mice bearing 4-week tumours (either 1 or
2) caused a significantly greater increase
in AST levels. This suggested that LPS
clearance caused more hepatocellular
damage in animals with 4-week tumours.
The comparable results for the OCT
levels are shown in Table III. Again,
injection of LPS into non-tumour-bearing
animals caused a significant rise in OCT
level. However, whilst the OCT levels in
mice bearing either Tumour 1 or Tumour 2
were significantly higher after injection of
LPS, this rise was significantly less than in
non-tumour-bearing animalsreceivingLPS.
There was no histological evidence of
liver necrosis in any animals. The only
visible difference between groups was a
transient accumulation ofneutrophil poly-
morphs in the sinusoids 4 h after i.v. endo-
toxin, which was more marked in 4-week
tumour-bearing mice than in control mice
given endotoxin. This effect had dis-
appeared after 24 h and was not seen in
tumour-bearing mice which had not re-
ceived endotoxin. In the 2 tumour-bearing
mice which died within 2-3 h after endo-
FIG. 2.-Lobule ofliver from a mouse bearing
the 5th transplant generation of Tumour 1
for one month. Carbon (8 mg/100 g body
wt) was injected i.v. 15 min before killing.
Carbon is present in sinus-lining macro-
phages throughout the lobule from portal
tract (PT) tocentralvein (CV). H. &E. x 90.
TABLE III.-Theplasma OCT levels in iu/l of (AxT6)Fl mice. The valuesfor ntice prior to
injection ofLPS werefor plasma pooledfrom groups of 5 mice. The valuesfor mice bled
24 h after i.v. injection of 25 ,ug LPS werefor individual animals
Group
Pre-LPS
No tumour Post-LPS
Tumour 1 Post-LPS
1 wk growth
2 wk growth
4 wk growth
Tumour 2 Post-LPS
1 wk growth
2 wk growth
4 wk growth
Ornithine carbamoyl transferase
C-
Range n Median
0-0- 5-3 14 1-7
0-0-26-3 19 12-9
0-8-28-8 7
0-0-22 1 9
00- 8-5 6
2-4-10-3 10
0-0-12-6 9
1-2-45-1 9
3-6
6-7
3-8
5.9
2-4
5-2
r--
From
From post-LPS,
pre-LPS no tumour
< 0-001
< 0-001
<0.05 NS
< 0-01 < 0-025
NS <0-01
< 0-001
NS
< 0 005
< 0-025
< 0-001
< 0-025
* Wilcoxon two-sample rank-sum test.
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FiG. 3.-Lobule of liver from a non-tumour-
bearing mouse, injected with carbon as for
Fig. 2. Carbon is present in sinus-lining
macrophages only in the periphery of the
lobules, near to the portal tract (PT) but is
absent from the centrilobular region around
the central vein (CV). H. & E. x 90.
toxin, there was an even more marked
hepatic accumulation of polymorphs, but
no liver necrosis.
DISCUSSION
Stimulation of reticulo-endothelial acti-
vity in tumour-bearing animals has in
most cases been found to be time-depen-
dent; for instance, Old et al. (1960) found
that in mice with various transplanted
tumours, hyperphagocytosis was most
marked throughout the phase of tumour
growth, and declined with the onset of
cachexia. RES stimulation was greatest
with tumours which differed from the
host at the H-2 locus, though a slight effect
was seen in mice with spontaneous mam-
mary tumours. Baum and Fisher (1972)
demonstrated an increase in the number of
macrophage precursors in the marrow of
C3H mice during the growth of C3H
mammary-tumour transplants. This was
observed after 4 days of tumour growth,
but the response was no longer seen at 2
weeks. Otu et al. (1977) measured marrow
macrophage colony formation, macro-
phage chemotaxis and in vivo RES clear-
ance in C57BL mice bearing transplants
ofthe Lewis lung carcinoma. They demon-
strated an initial decrease, followed by a
phase of increase and subsequent decrease
in all these parameters. The phase of
increased function spanned Days 7-14
after tumour transplantation.
The in vitro tumoricidal activity of
macrophages is increased in cells taken
from tumour-bearing animals (Kirchner
et al., 1975) though it is unclear whether
this correlates with an overall increase in
reticulo-endothelial function.
In the present experiments several
effects of an increased tumour load on the
hepatic macrophages were noted. There
was an increase in liver weight associated
with increased numbers of large mono-
nuclear cells in the sinusoids, singly and in
clumps. In addition, carbon was extracted
from the blood by the sinus-lining phago-
cytes throughout the liver lobule, whereas
in non-tumour-bearing mice carbon was
only seen in the periportal areas. Finally,
there was an increased hepatic clearance
of i.v. injected SRBC. Whether these
changes represent both recruitment of
new macrophages and their activation has
not been determined, and it is unclear
whether this is a critical distinction
(Ferluga et al., 1978).
I.v. injection of LPS led to a rise in the
plasma concentration of AST 24 h later,
and this effect was greatest in mice bearing
the greatest tumour load. The rise in
enzyme levels was, however, much less
than in similar experiments where RES
function was stimulated by injection of
C. parvum (Ferluga & Allison, 1978).
Although overt hepatic necrosis was not
seen histologically, it is likely that the rise
in AST levels in the present experiments
represents endotoxin-induced liver dam-
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age, as the liver is the main site of
endotoxin clearance from the bloodstream
(Wiznitzer et al., 1960; Rutenberg et al.,
1967). Minimal hepatocellular damage
without histological evidence of overt liver
necrosis has been documented during
Kupffer-cell endocytosis of LPS (Ruiter
et al., 1980) and other particles (Bradfield
& Souhami, 1980).
Ultrastructurally, endotoxin is cleared
from blood into Kupffer cells, where it can
be visualised within phagosomes (Balis
et al., 1978; Ruiter et al., 1980). It has also
been visualized within the polymorpho-
nuclear cells sequestered in liver sinusoids
(Balis et al., 1978).
As the enzyme AST is not confined to
hepatocytes, it also seemed important to
study the changes in OCT levels in plasma
following LPS challenge, since the latter
is released only from hepatic mitochondria
(Vassef, 1978). There was indeed a rise in
the serum levels of this enzyme after LPS
injection, but it was greater in non-
tumour-bearing mice than in those with a
tumour. The reason for this discrepancy
is unclear. One possibility is that the
increased macrophage activity in tuinour-
bearing mice might lead to an increased
rate of elimination of OCT. Alternatively,
it might be that the liver-cell damage is
less in tumour-bearing mice, the rise in
AST being due in part to its liberation from
extra-hepatic sources. Tumours can pro-
duce a factor which blocks LPS-induced
macrophage tumouricidal activity in vitro
(Cheung et al., 1979) though this may not
be relevant to the present model.
The level of endotoxin-induced AST
release correlated with tumour bulk,
whereas the effect on OCT levels showed no
such relationship. In addition, the presence
of tumour appeared to make the mice
more, rather than less, sensitive to the
toxic effects ofendotoxin, so that a number
ofthe tumour-bearing mice became listless
and 2 died within 4 h of injection. These 2
mice showed an excessive accumulation of
neutrophil polymorphs in liver sinusoids.
Non-tumour-bearing mice remained clini-
cally healthy after LPS.
It is of interest that there was no
evidence for an increased hepatoxicity of
endogenous endotoxin in tumour-bearing
mice in that the basal levels of AST and
OCT were similar in both groups. There is,
however, no way ofjudging the sensitivity
ofthis assessment.
The degree and mechanism of hepato-
cellular damage during hepatic clearance
of endotoxin in this and other models has
aroused considerable speculation (Ferluga
& Allison, 1978; Bradfield & Wells 1978;
Ruiter et al., 1980). In particular it is not
known whether this is another example of
adjacent-tissue damage by the release of
cytotoxic factors from macrophages during
phagocytosis (Davies & Allison, 1976).
The fact that, in these experiments, the
degree of liver damage appeared to corre-
late with the increased distribution and
activity of hepatic phagocytes, would
support the hypothesis that hepatocellular
damage results from lysosomal-enzyme
leakage from sinus-lining macrophages
(Weissman & Thomas, 1964; Balis et al.,
1978; Ferluga & Allison, 1978). However,
other possible mechanisms exist. These
include the release of lysosomal enzymes
from the sequestered polymorphonuclear
cells (Cline et al., 1968; Bannatyne et al.,
1977) tissue anoxia due to local deposition
of fibrin (Balis et al., 1978) and direct
hepatotoxicity by the endotoxin (Ruiter
etal., 1980).
Humans are said to be more sensitive
than mice to endotoxin (Liehr & Griin,
1979) but are protected from the endotoxin
which is normally present in the portal
blood (Prytz et al., 1976) by efficient
hepatic endocytosis. However in patients
with tumours this uptake mechanism is
often hyperactive, as shown by studies of
1311-labelled heat aggregated albumin
clearance (Magarey & Baum, 1970). The
present results suggest that this may make
the liver more susceptible to endotoxin
damage, which may be reflected in some
of the non-specific changes seen in liver
histology and some of the morbidity
associated with cancer in clinical
practice.
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